EYEPOINT PHARMACEUTICALS US, INC. logo

EYEPOINT PHARMACEUTICALS US, INC.

23 Marks
Corp.
First Filed:Apr 10, 2015Latest Filed:Jun 19, 2023Address:Suite C400, Watertown, MA 02472

Portfolio Overview

Previous
30

Top Classes

Class 5
Pharmaceuticals
22(96%)
Class 36
Insurance, Financial Services & Real Estate
1(4%)

TTAB Proceedings

Total Proceedings
12
As Plaintiff
1(8%)
As Defendant
11(92%)

Top Firms

Loading...

Trademark Activity Timeline(2015 – 2023)

Trademark Portfolio

53 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
OPVUE
OPVUE
Trademark
Word
ABANDONED
Owner:
Serial:98048432
Filed:Jun 19, 2023
Classes:5
MAINTIK
MAINTIK
Trademark
Word
ABANDONED
Owner:
Serial:97724759
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
OPVU
OPVU
Trademark
Word
ABANDONED
Owner:
Serial:97724775
Filed:Dec 20, 2022
Classes:5
RETISTA
RETISTA
Trademark
Word
ABANDONED
Owner:
Serial:97724860
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
RYVIZ
RYVIZ
Trademark
Word
ABANDONED
Owner:
Serial:97724877
Filed:Dec 20, 2022
Classes:5
TEVIDO
TEVIDO
Trademark
Word
ABANDONED
Owner:
Serial:97724822
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VISITAIN
VISITAIN
Trademark
Word
ABANDONED
Owner:
Serial:97724796
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VIZIQ
VIZIQ
Trademark
Word
ABANDONED
Owner:
Serial:97724813
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VUDUR
VUDUR
Trademark
Word
ABANDONED
Owner:
Serial:97724898
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
MAINTIQ
MAINTIQ
Trademark
Word
ABANDONED
Owner:
Serial:97714084
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
OCUDUR
OCUDUR
Trademark
Word
ABANDONED
Owner:
Serial:97714125
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
OCUNIB
OCUNIB
Trademark
Word
ABANDONED
Owner:
Serial:97714144
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
RETYSTA
RETYSTA
Trademark
Word
ABANDONED
Owner:
Serial:97714101
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VODURA
VODURA
Trademark
Word
ABANDONED
Owner:
Serial:97714112
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VORVIZIX
VORVIZIX
Trademark
Word
ABANDONED
Owner:
Serial:97714132
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
TREAT AND MAINTAIN
TREAT AND MAINTAIN
Trademark
Word
ABANDONED
Owner:
Serial:97309325
Filed:Mar 12, 2022
Classes:5
EYEPOINT ASSIST
EYEPOINT ASSIST
Service Mark
Word
ABANDONED
Owner:
Serial:88272773
Filed:Jan 23, 2019
Classes:36
Description: "ASSIST"
ACUITY PHARMACEUTICALS
ACUITY PHARMACEUTICALS
Trademark
Word
ABANDONED
Owner:
Serial:87791663
Filed:Feb 9, 2018
Classes:5
Description: "PHARMACEUTICALS"
DORATIQ
DORATIQ
Trademark
Word
ABANDONED
Owner:
Serial:87684061
Filed:Nov 14, 2017
Classes:5
DORTIQ
DORTIQ
Trademark
Word
ABANDONED
Owner:
Serial:87684078
Filed:Nov 14, 2017
Classes:5
UVIEY
UVIEY
Trademark
Word
ABANDONED
Owner:
Serial:87250560
Filed:Nov 29, 2016
Classes:5
MILLISERT
MILLISERT
Trademark
Word
ABANDONED
Owner:
Serial:86593767
Filed:Apr 10, 2015
Classes:5
UVISERT
UVISERT
Trademark
Word
ABANDONED
Owner:
Serial:86593739
Filed:Apr 10, 2015
Classes:5
EYEPOINT
EYEPOINT
Service Mark
Word
Previous
REGISTERED
Owner:
Serial:99220120
Filed:Jun 5, 2025
Classes:42
Registration:8108350
Registered:Jan 20, 2026
Description: Scientific and technological research in the field of eye diseases and conditions; design and development of pharmaceuticals preparations, inserts, implants and technology in the field of ophthalmology.
DURAJECT
DURAJECT
Trademark
Word
Previous
PENDING
Owner:
Serial:99975291
Filed:May 5, 2025
Classes:5
Description: Ophthalmological drugs packaged in a drug delivery system
DURAJECT
DURAJECT
Trademark
Word
Previous
PENDING
Owner:
Serial:99169992
Filed:May 5, 2025
Classes:10
Description: Ophthalmological drugs packaged in a drug delivery system; Medical and surgical apparatuses and instruments for use in ophthalmic procedures and which are sold into and used by ophthalmology practices
DURASERT E
DURASERT E
Trademark
Word
Previous
PENDING
Owner:
Serial:98677791
Filed:Aug 1, 2024
Classes:10
Description: Injectable sustained drug delivery systems consisting of a bioerodible matrix for delivering pharmaceuticals via injection into the posterior segment of the eye
DURAJECT
DURAJECT
Trademark
Word
Previous
PENDING
Owner:
Serial:98414251
Filed:Feb 21, 2024
Classes:10
Description: Medical and surgical apparatus and instruments for use in ophthalmic procedures
RETINVYU
RETINVYU
Trademark
Word
Previous
PENDING
Owner:
Serial:98093577
Filed:Jul 20, 2023
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
DURAVYU
DURAVYU
Trademark
Word
Previous
PENDING
Owner:
Serial:98073717
Filed:Jul 6, 2023
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
DURVIEW
DURVIEW
Trademark
Word
Previous
PENDING
Owner:
Serial:98048464
Filed:Jun 19, 2023
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
DURVUE
DURVUE
Trademark
Word
Previous
PENDING
Owner:
Serial:98048453
Filed:Jun 19, 2023
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
RETINVUE
RETINVUE
Trademark
Word
Previous
PENDING
Owner:
Serial:98048437
Filed:Jun 19, 2023
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VIZITAIN
VIZITAIN
Trademark
Word
Previous
PENDING
Owner:
Serial:98048447
Filed:Jun 19, 2023
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
VIZTAIN
VIZTAIN
Trademark
Word
Previous
PENDING
Owner:
Serial:98048440
Filed:Jun 19, 2023
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
DURASERT E
DURASERT E
Trademark
Word
Previous
PENDING
Owner:
Serial:97858204
Filed:Mar 27, 2023
Classes:5
Description: Injectable pharmaceutical preparations comprising erodible ingredients that facilitate the delivery of pharmaceuticals via injection into the posterior segment of the eye for the treatment of eye diseases and conditions of the retina, namely, wet age-related macular degeneration, non-proliferative diabetic retinopathy, diabetic macular edema and retinal vein occlusion and excluding dry eye, conjunctivitis, glaucoma and bacterial eye infections
DURAVUE
DURAVUE
Trademark
Word
Previous
PENDING
Owner:
Serial:97767088
Filed:Jan 25, 2023
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
DURAMAC
DURAMAC
Trademark
Word
Previous
PENDING
Owner:
Serial:97724835
Filed:Dec 20, 2022
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
DURAVU
DURAVU
Trademark
Word
Previous
PENDING
Owner:
Serial:97724740
Filed:Dec 20, 2022
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
RETIVU
RETIVU
Trademark
Word
Previous
PENDING
Owner:
Serial:97724847
Filed:Dec 20, 2022
Classes:5
Description: Injectable pharmaceutical preparations for use by ophthalmologists, or other medical professionals qualified to administer ocular injections, for the treatment of eye diseases and conditions, excluding the treatment of cancer
RYLYX
RYLYX
Trademark
Word
Previous
PENDING
Owner:
Serial:97724887
Filed:Dec 20, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
RETINVU
RETINVU
Trademark
Word
Previous
PENDING
Owner:
Serial:97714147
Filed:Dec 12, 2022
Classes:5
Description: Pharmaceutical preparations for the treatment of eye diseases and conditions
WITH AN EYE ON PATIENTS
WITH AN EYE ON PATIENTS
Trademark
Word
Previous
REGISTERED
Owner:
Serial:97272238
Filed:Feb 17, 2022
Classes:5
Registration:7186053
Registered:Oct 10, 2023
Description: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease
EYEPOINT
EYEPOINT
Trademark
Word
Previous
REGISTERED
Owner:
Serial:88546557
Filed:Jul 29, 2019
Classes:5
Registration:6133661
Registered:Aug 25, 2020
Description: House mark for drug delivery agents consisting of polymer compounds that facilitate delivery of pharmaceutical preparations for the treatment of eye diseases and conditions; house mark for pharmaceutical preparations for ocular or intraocular surgery; house mark for pharmaceutical preparations for the treatment of ocular diseases and conditions
EYEPOINT PHARMACEUTICALS
EYEPOINT PHARMACEUTICALS
Trademark
Word
Previous
REGISTERED
Owner:
Serial:88546550
Filed:Jul 29, 2019
Classes:5
Registration:6133660
Registered:Aug 25, 2020
Description: House mark for drug delivery agents consisting of polymer compounds that facilitate delivery of pharmaceutical preparations for the treatment of eye diseases and conditions; house mark for pharmaceutical preparations for ocular or intraocular surgery; house mark for pharmaceutical preparations for the treatment of ocular diseases and conditions
YUTIQ
YUTIQ
Trademark
Combined
Previous
REGISTERED
Owner:
Serial:88167946
Filed:Oct 24, 2018
Classes:5, 10
Registration:6153947
Registered:Sep 15, 2020
Description: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease | Sustained drug delivery systems for ocular drugs
88039095
88039095
Trademark
Design
Previous
REGISTERED
Owner:
Serial:88039095
Filed:Jul 16, 2018
Classes:5, 10
Registration:5939136
Registered:Dec 17, 2019
Description: House mark for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions of the eyes; house mark for pharmaceutical preparations for ocular or intraocular surgery; house mark for pharmaceutical preparations for the treatment of eye diseases and conditions; House mark for sustained drug delivery systems for pharmaceuticals
88039087
88039087
Trademark
Design
Previous
REGISTERED
Owner:
Serial:88039087
Filed:Jul 16, 2018
Classes:5, 10
Registration:5939135
Registered:Dec 17, 2019
Description: House mark for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions of the eyes; house mark for pharmaceutical preparations for ocular or intraocular surgery; house mark for pharmaceutical preparations for the treatment of eye diseases and conditions; House mark for sustained drug delivery systems for pharmaceuticals
EYEPOINT
EYEPOINT
Trademark
Word
Previous
REGISTERED
Owner:
Serial:87821911
Filed:Mar 6, 2018
Classes:5, 10
Registration:5875067
Registered:Oct 1, 2019
Description: House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease; House mark for sustained drug delivery systems for pharmaceuticals
EYEPOINT PHARMACEUTICALS
EYEPOINT PHARMACEUTICALS
Trademark
Word
Previous
REGISTERED
Owner:
Serial:87821925
Filed:Mar 6, 2018
Classes:5, 10
Registration:5875068
Registered:Oct 1, 2019
Description: House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease; "PHARMACEUTICALS"; House mark for sustained drug delivery systems for pharmaceuticals
DURASERT
DURASERT
Trademark
Word
Previous
REGISTERED
Owner:
Serial:87291781
Filed:Jan 6, 2017
Classes:5, 10
Registration:5903604
Registered:Nov 5, 2019
Description: Injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, namely, uveitis and retinal disease; Injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior chamber of the eye
DELIVERING INNOVATION TO THE EYE
DELIVERING INNOVATION TO THE EYE
Trademark
Word
Previous
REGISTERED
Owner:
Serial:87250608
Filed:Nov 29, 2016
Classes:5, 10
Registration:5874660
Registered:Oct 1, 2019
Description: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease; Sustained drug delivery systems for ocular drugs
YUTIQ
YUTIQ
Trademark
Word
Previous
CANCELLED
Owner:
Serial:87250580
Filed:Nov 29, 2016
Classes:5, 10
Registration:5763976
Registered:May 28, 2019
Description: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and [ retinal vein occlusion, macular edema, macular disease, ] retinal disease; [ and glaucoma; ] pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis and [ retinal vein occlusion, macular edema, macular disease, age-related macular degeneration, ] retinal disease [ and glaucoma ] | Sustained drug delivery systems for ocular drugs